Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-037464
Filing Date
2025-08-04
Accepted
2025-08-04 16:41:51
Documents
83
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20250630.htm   iXBRL 10-Q 1690458
2 EX-10.2 ardx-20250630xex102.htm EX-10.2 57736
3 EX-10.3 ardx-20250630xex103.htm EX-10.3 18627
4 EX-31.1 ardx-20250630xex311.htm EX-31.1 9603
5 EX-31.2 ardx-20250630xex312.htm EX-31.2 9641
6 EX-32.1 ardx-20250630xex321.htm EX-32.1 6358
12 ardx-20250630_g1.jpg GRAPHIC 75659
13 image_0a.jpg GRAPHIC 49118
  Complete submission text file 0001628280-25-037464.txt   8286233

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20250630.xsd EX-101.SCH 53509
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20250630_cal.xml EX-101.CAL 72079
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20250630_def.xml EX-101.DEF 241827
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20250630_lab.xml EX-101.LAB 634307
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20250630_pre.xml EX-101.PRE 453758
86 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20250630_htm.xml XML 1221811
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 251180994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)